EZH2 and acute myeloid leukemia: The authors suggested that despite the compromised proliferative capacity in the setting of EZH2 loss, induction of cytokine production in the tumor microenvironment might lead to expansion of the dysplastic myeloid clones while upregulation of EZH2 can promote progression to AML [30].